Climb Bio (CLYM) Operating Leases (2022 - 2026)

Climb Bio (CLYM) posted Operating Leases of $216000.0 for Q1 2026, down 24.21% on a QoQ basis from $285000.0 in Q4 2025, and down 32.29% year-over-year from $319000.0 in Q1 2025.

Climb Bio (CLYM) Operating Leases (2022 - 2026) Analysis & Trends

Climb Bio's Operating Leases history runs 5 years deep, the most recent figure standing at $216000.0 for Q1 2026.

  • Quarterly Operating Leases fell 32.29% year-over-year to $216000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $216000.0 (down 32.29% YoY) and the FY2025 annual result came in at $285000.0, down 24.0% from the prior year.
  • Operating Leases was $216000.0 for Q1 2026 at Climb Bio, down from $285000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $571000.0 in Q3 2022 and bottomed at $15000.0 in Q4 2023.
  • A 5-year average of $267714.3 and a median of $270500.0 in 2022 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2023 — Operating Leases tumbled 91.67% — and 2024, when it jumped 2400.0%.
  • Climb Bio's Operating Leases stood at $180000.0 in 2022, then tumbled by 91.67% to $15000.0 in 2023, then soared by 2400.0% to $375000.0 in 2024, then fell by 24.0% to $285000.0 in 2025, then declined by 24.21% to $216000.0 in 2026.
  • Business Quant data shows CLYM's Operating Leases at $216000.0 in Q1 2026, $285000.0 in Q4 2025, and $352000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Climb Bio 870.33 Mn 870.33 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 216,000.00
Dec 31, 2025 285,000.00
Sep 30, 2025 352,000.00
Jun 30, 2025 417,000.00
Mar 31, 2025 319,000.00
Dec 31, 2024 375,000.00
Dec 31, 2023 15,000.00
Sep 30, 2023 58,000.00
Jun 30, 2023 100,000.00
Mar 31, 2023 223,000.00
Dec 31, 2022 180,000.00
Sep 30, 2022 571,000.00
Jun 30, 2022 256,000.00
Mar 31, 2022 381,000.00